Green engineering of TMC-CMS nanoparticles decorated graphene sheets for targeting M. tuberculosis

Our current work intends to primarily engineer a new type of antibacterial composite by preparing a highly biocompatible graphene sheet decorated with TMC-CMS IPNs nanoparticles utilizing one-pot, green, cost-effective ultrasonication approach. The microstructure of as-formed materials was chemically confirmed using various analytical techniques such as 1H-NMR, FTIR, UV/vis, SEM, and TEM. TEM data has proved the formation of uniformly distributed TCNPs on graphene surfaces with a small particle size of-22 nm compared with that of pure nanoparticles (-30 nm). The inhibitory activity of these developed materials was examined against the growth of three different M. tuberculosis pathogens and in a comparison with the isoniazid drug as a standard anti-tuberculosis drug. The TCNPs@GRP composite attained MIC values of 0.98, 3.9, and 7.81 mu g/mL for inhibiting the growth of sensitive, MDR, and XDR M. tuberculosis pathogens compared to the bare TCNPs (7.81, 31.25, >125 mu g/mL) and the isoniazid drug (0.24, 0, 0 mu g/mL), respectively. This reveals a considerable syn-ergism in the antituberculosis activity between TCNPs and graphene nanosheets. Cytotoxicity of the TCNPs@GRP was examined against normal lung cell lines (WI38) and was found to have cell viability of 100% with the concentration range of 0.98-7.81 mu g/mL.

Automated summary

Our study aims to engineer a new type of antibacterial composite by decorating a highly biocompatible graphene sheet with TMC-CMS IPNs nanoparticles using a one-pot, green, cost-effective ultrasonication approach. Various analytical techniques were used to chemically confirm the microstructure of the materials. The composite of TCNPs@GRP showed significant synergism in inhibiting the growth of M. tuberculosis pathogens compared to bare TCNPs and isoniazid drug.